AU619586B2 - Pharmaceutical product which can be applied transdermally containing pharmaceutically usable glycosides - Google Patents

Pharmaceutical product which can be applied transdermally containing pharmaceutically usable glycosides Download PDF

Info

Publication number
AU619586B2
AU619586B2 AU41016/89A AU4101689A AU619586B2 AU 619586 B2 AU619586 B2 AU 619586B2 AU 41016/89 A AU41016/89 A AU 41016/89A AU 4101689 A AU4101689 A AU 4101689A AU 619586 B2 AU619586 B2 AU 619586B2
Authority
AU
Australia
Prior art keywords
ethoxylised
glycosides
pharmaceutical product
pharmaceutically usable
ethylene oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU41016/89A
Other languages
English (en)
Other versions
AU4101689A (en
Inventor
Karl Heinrich Dr. Pegel
Hans Dr. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roecar Holdings Netherlands Antilles NV
Original Assignee
Roecar Holdings NV
Roecar Holdings Netherlands Antilles NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roecar Holdings NV, Roecar Holdings Netherlands Antilles NV filed Critical Roecar Holdings NV
Publication of AU4101689A publication Critical patent/AU4101689A/en
Application granted granted Critical
Publication of AU619586B2 publication Critical patent/AU619586B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AU41016/89A 1988-09-01 1989-09-01 Pharmaceutical product which can be applied transdermally containing pharmaceutically usable glycosides Ceased AU619586B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3829640A DE3829640C1 (enExample) 1988-09-01 1988-09-01
DE3829640 1988-09-01

Publications (2)

Publication Number Publication Date
AU4101689A AU4101689A (en) 1990-03-08
AU619586B2 true AU619586B2 (en) 1992-01-30

Family

ID=6362037

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41016/89A Ceased AU619586B2 (en) 1988-09-01 1989-09-01 Pharmaceutical product which can be applied transdermally containing pharmaceutically usable glycosides

Country Status (10)

Country Link
EP (1) EP0356754B1 (enExample)
JP (1) JPH02180831A (enExample)
AT (1) ATE72982T1 (enExample)
AU (1) AU619586B2 (enExample)
DE (1) DE3829640C1 (enExample)
DK (1) DK430889A (enExample)
FI (1) FI893776L (enExample)
GR (1) GR1000353B (enExample)
NO (1) NO893503L (enExample)
PT (1) PT91572B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103765D0 (sv) * 2001-11-09 2001-11-09 Astrazeneca Ab New use
DE10312000A1 (de) * 2003-03-19 2004-09-30 Cognis Deutschland Gmbh & Co. Kg Ethercarbonsäureester von Sterolen bzw. Stanolen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4333926A (en) * 1975-05-22 1982-06-08 Nippon Shinyaku Co., Ltd. Steryl-β-D-glucoside pharmaceutical compositions and use
US4146649A (en) * 1976-10-14 1979-03-27 Faberge, Incorporated Skin moisturizing composition containing a polyethoxy fatty alcohol and a polyethoxy glycoside
FR2380030A1 (fr) * 1977-02-09 1978-09-08 Christiaens Sa A Composition pharmaceutique contenant de la gitoxine
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
DE3829641A1 (de) * 1988-09-01 1990-03-15 Roecar Holdings Nv Transdermal anwendbare pharmazeutische zubereitungen mit sterolinen und/oder spiroketalinen

Also Published As

Publication number Publication date
PT91572B (pt) 1995-05-31
AU4101689A (en) 1990-03-08
JPH02180831A (ja) 1990-07-13
DE3829640C1 (enExample) 1990-04-26
NO893503D0 (no) 1989-08-31
GR890100519A (en) 1990-10-31
ATE72982T1 (de) 1992-03-15
EP0356754A1 (de) 1990-03-07
EP0356754B1 (de) 1992-03-04
FI893776A7 (fi) 1990-03-02
FI893776A0 (fi) 1989-08-10
DK430889D0 (da) 1989-08-31
PT91572A (pt) 1990-03-30
NO893503L (no) 1990-03-02
DK430889A (da) 1990-03-02
FI893776L (fi) 1990-03-02
GR1000353B (el) 1992-06-25

Similar Documents

Publication Publication Date Title
US6228852B1 (en) Transdermal application of naturally occurring steroid hormones
US5869090A (en) Transdermal delivery of dehydroepiandrosterone
DE69721377T2 (de) Arzneimittel zur transdermalen Verabreichung von einem Östrogen oder Progestin oder einer Mischung davon
DE69532927T2 (de) Cyclophasiges hormonverfahren das antiprogestin und progestin enthält
AU630370B2 (en) Pharmaceutical preparations which can be applied transdermally, containing sterolins and/or spiroketalins
US3890438A (en) Compositions and methods for reducing blood cholesterol
NO803916L (no) Fremgangsmaate ved fremstilling av en terapeutisk virksom blanding
WO2013028177A1 (en) Formulations of deoxycholic acid and salts thereof
AU2016349516A1 (en) Treatments of accumulated fat with deoxycholic acid and salts thereof
US5576346A (en) Process for treating uremic pruritus
DE3836862A1 (de) Mittel zur transdermalen applikation von steroidhormonen
EP0216303A2 (en) External medication
AU619586B2 (en) Pharmaceutical product which can be applied transdermally containing pharmaceutically usable glycosides
DE60101206T2 (de) Transdermale verabreichung von lasofoxifen
PL206702B1 (pl) Zastosowanie kompozycji żelowej do leczenia hipogonadyzmu
US5166194A (en) Transdermally applicable pharmaceutical preparations having a pharmaceutically usable glycoside content
US5552436A (en) Process for treating hemangioma
JPH0466847B2 (enExample)
Demers et al. The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancer
EP0850647B1 (fr) Application de composés stéroides substitués en ll pour la fabrication de médicaments ayant une activité estrogène dissociée
DE102004023984A1 (de) Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
DE3904674A1 (de) Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen
EP0927029A1 (en) Novel methods
DE4326948C1 (de) Verwendung von natürlichen Östrogenen zur Verlangsamung des Alterungsprozesses bei Männern
Cohen et al. Dissolution of cholesterol gallstones by bile acids in the prairie dog